D.C. Medical Cannabis Sales Bounce Back to $10.24M in September

D.C.'s medical cannabis market bounced back in September 2026, with total revenue climbing to $10.24 million. The rebound was powered mostly by the supply side of the industry instead of the storefronts, which tells an interesting story about how the District's market is working right now.

The biggest mover was wholesale cultivation, which surged 17.9 percent. Processing also had a solid month, rising 15.2 percent. Those two segments sit upstream of the dispensary counter, so growth there often reflects businesses restocking, moving inventory, and building up product before it reaches the shelf. In other words, the supply chain picked up speed, and that was enough to lift the whole market.

Retail, meanwhile, saw minor dips. The declines were small and were more than offset by the gains in cultivation and processing, so the overall picture stayed positive. A small retail slowdown in a single month isn't necessarily cause for alarm, since monthly numbers can swing based on timing, purchasing patterns, and the pace of inventory movement.

Another figure worth noting is the size of the patient base. The number of resident patients reached nearly 150,000, which is a sizable group for a jurisdiction of D.C.'s size. It suggests that the medical program remains an important part of how people in the District access cannabis, even as other parts of the local market continue to evolve.

For patients, a healthy supply chain is generally good news, since it points toward more consistent availability of products. For operators and investors, the numbers offer a snapshot of a market that still has momentum, with growth coming from the businesses that grow and process the plant as much as from those that sell it.